Jiayi He

ORCID: 0000-0003-4361-3379 · 6 papers in corpus · active 2018-2023

Study types

  • article 5
  • review 1

Condition tags

  • adenomyosis 5
  • dysmenorrhea 2
  • endometriosis 2
article 2023
JAMA network open ·doi:10.1001/jamanetworkopen.2023.17860

Importance: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. Objective: To determine whether mifepristone…

article 2021
·doi:10.2139/ssrn.3897694
article 2020
Annals of translational medicine ·doi:10.21037/atm-20-3420

BACKGROUND: Although the levonorgestrel-releasing intrauterine device (LNG-IUD) has been widely applied in the treatment of adenomyosis, not all the patients are satisfied with its efficacy. The present retrospective study aimed to investig…

article 2020
International journal of medical sciences ·doi:10.7150/ijms.39252

Background: Adenomyosis is a quite common gynecological disorder and above 30% of patients have typical secondary and progressive dysmenorrhea. Current treatments still have many disadvantages and thereby the novel treatment aiming to relie…

article 2019
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.14866

Adenomyosis is also called internal endometriosis and affects about 20% of reproductive-aged women. It seriously reduces life quality of patients because current drug therapies face with numerous challenges. Long-term clinical application o…

review 2018
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences ·doi:10.3785/j.issn.1008-9292.2018.08.15

A large number of studies have shown that the oxidative imbalance is common in patients with endometriosis. Abnormal respiratory chain of mitochondrial, estrogen metabolism imbalance, iron overload, and ectopic foci may increase active oxyg…